Friday Gevo Inc (GEVO) $GEVO opened at 1.05 hitting the high price of 1.08 and a day low of 1.03 with a total volume of 224,800. GEVO had a previous close of 1.06 and has been seeing an average volume of 1,584,425.
Overall Average: 40% Sell
Recent stock forum discussions about GEVO http://investorshangout.com/search?q=GEVO&...mp;yt0=Go!
Energy Sector Stocks Technical Data -- Research on Northern Tier Energy, Gevo, MPC, and Tesoro
PR Newswire - Fri May 02, 7:00AM CDT
The trading session on Thursday, May 01, 2014 ended on a mixed note as the Dow Jones Industrial Average finished at 16,558.87, down 0.13% and the NASDAQ Composite closed at 4,127.45, up 0.31%. The S&P 500 finished the day 0.01% lower at 1,883.68. During the trading session, five out of ten sectors finished on a positive note. The S&P 500 Energy Sector Index ended the day 0.36% lower at 683.84, while the index has gained 12.02% in the previous three months. Investor-Edge has initiated coverage on the following equities: Northern Tier Energy L.P. (NYSE: NTI), Gevo Inc. (NASDAQ: GEVO), Marathon Petroleum Corp. (NYSE: MPC) and Tesoro Corp. (NYSE: TSO). Free technical research on NTI, GEVO, MPC and TSO can be downloaded upon signing up at: (full story)
4 Stocks Under $10 Making Big Moves
at The Street - Fri Apr 25, 6:35AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. (full story)
Gevo, Inc. (GEVO) Stock Partially Gives Back Tuesday Gains
at The Street - Wed Apr 23, 2:16PM CDT
Gevo, Inc. (GEVO) stock is tracing lower on Wednesday after making big gains on Tuesday. The renewable biofuel developer soared earlier in the week after announcing Lufthansa will evaluate the company's renewable jet fuel with the aim to approve its... (full story)
Nasdaq stocks posting largest volume increases
AP - Tue Apr 22, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading: (full story)
Why Gevo, Inc. (GEVO) Stock Is Up Today
at The Street - Tue Apr 22, 11:56AM CDT
Gevo, Inc. (GEVO) is soaring on Tuesday after announcing Lufthansa will evaluate the company's renewable jet fuel with the aim to approve its alcohol-to-jet fuel (ATJ) formula for commercial aviation use. Lufthansa will test the fuel with the support... (full story)
Lufthansa to Evaluate Gevo's Renewable Jet Fuel
GlobeNewswire - Tue Apr 22, 11:00AM CDT
Gevo, Inc. (Nasdaq:GEVO), the world's only commercial producer of renewable isobutanol, announced today that it has come to an agreement with Lufthansa to evaluate Gevo's renewable jet fuel with the goal of approving Gevo's alcohol-to-jet fuel (ATJ) for commercial aviation use. Lufthansa's testing is being supported through work with the European Commission. (full story)
Global Synthetic Biology Market 2013-2019 - Genome Engineering, DNA Sequencing, Bioinformatics & Biological Components and Integrated Systems
M2 - Tue Apr 22, 5:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/29nxfg/synthetic_biology) has announced the addition of the "Synthetic Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019" report to their offering. Synthetic biology is a synergistic combination of biology and engineering for the construction of artificial biological system in order to gain desired functions (i.e. to reduce cost or improve efficacy). It comprises nascent technologies that enable synthesis of novel biological parts and organisms that are used in the field of healthcare, chemicals, agriculture and others (biosecurity, R&D and energy and environment). The synthetic biology market is witnessing rapid growth owing to increase in demand for renewable fuels and bio-based chemicals and inexpensive drugs and vaccines that utilizes synthetic biology technologies and products. In addition, participation of various organizations such as BioBricks, DIYbio and SynBERC, for the development of synthetic biology field will further augment the growth of this market during the forecast period. However, high cost and strict regulations to use synthetic biology techniques hampers the growth of this market. Synthetic biology market is segmented mainly by products, by technologies and by applications. Synthetic biology, by product segment is classified as core products and enabling products. Core products are further segmented into synthetic DNA, synthetic genes, synthetic cells, XNA and chassis organisms. The synthetic biology market by core products was dominated by synthetic DNA market in 2012 owing to the commercial availability of this product, compared to other synthetic core products expected to be launched in the market in coming years. Synthetic biology market by technologies is segmented as genome engineering, DNA sequencing, bioinformatics and biological components and integrated systems. Genome engineering technology can be used to modify genetic foods, gene cloning and gene therapy. Thus, application of genome engineering increases the scope to utilize this technique and hence accentuates the growth of this market. Applications of synthetic biology are healthcare, chemicals, agriculture and others. Synthetic biology in healthcare holds largest market share in terms of revenue due to high utilization of synthetic biology techniques to produce cheap drugs and vaccines. Also, commercial availability of synthetic DNA and synthetic genes supports the growth of the healthcare application in the synthetic biology market. Agriculture segment is expected to grow at the highest growth rate during the forecast period. The global synthetic biology market is segmented into the following categories: Products - Core Products - - Synthetic DNA - - Synthetic Genes - - Synthetic Cells - - XNA (Xeno Nucleic Acid) - - Chasis Organisms - Enabling Products - - DNA Synthesis - - Oligonucleotide Synthesis Technologies - Genome Engineering - DNA Sequencing - Bioinformatics - Biological Components and Integrated Systems Applications - Healthcare - Chemicals (Including Bio-Fuels) - Agriculture - Others (Biosecurity, R&D, Energy and Environment) Key Topics Covered: - Introduction - Executive Summary - Market Overview - Global Synthetic Biology Market, by Products - Global Synthetic Biology Market, by Technologies - Global Synthetic Biology Market, by Applications - Global Synthetic Biology Market, by Geography - Competitive Landscape - Recommendations - Company Profiles - Agrivida, Inc. - Amyris, Inc. - Algenol Biofuels, Inc. - ATG:biosynthetics GmbH - Bayer AG - Bristol-Myers Squibb - BIONEER CORPORATION - Biosearch Technologies, Inc. - CBC Comprehensive Biomarker Center GmbH - Cobalt Technologies - DuPont, Inc. - Evolva SA - Exxon Mobil Corporation - Ginkgo Bioworks - GeneWorks Pty Ltd. - Genomatica, Inc. - GeneScript Corporation - Gevo, Inc. - Green Biologics Limited - New England Biolabs, Inc. - OriGene Technologies, Inc. - REG Life Sciences, LLC - Royal DSM - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/29...ic_biology (full story)
Gevo to Host Conference Call to Report First Quarter Financial Results on May 14, 2014
GlobeNewswire - Mon Apr 21, 8:00AM CDT
Gevo, Inc. (Nasdaq:GEVO) today announced that the company will host a conference call on Wednesday, May 14, 2014 at 4:30 p.m. EDT (2:30 p.m. MDT) to report its financial results for the first quarter ended March 31, 2014 and provide an update on recent corporate highlights. (full story)
Gevo, Inc. (GEVO) Enters Oversold Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 9:46AM CDT
Gevo, Inc. (GEVO) Enters Oversold Territory (full story)
Zacks Rank #1 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday (full story)
Why Gevo Inc. (GEVO) Stock Is Plummeting After Hours
at The Street - Tue Mar 25, 3:43PM CDT
Gevo Inc. (GEVO) is tumbling in extending trading after posting a wider-than-expected loss in its year-ending quarter. (full story)
Gevo Reports Fourth Quarter 2013 Financial Results
GlobeNewswire - Tue Mar 25, 3:30PM CDT
Optimizing utilization and cash flows of Luverne plant by producing both isobutanol and ethanol (full story)
U.S. Geothermal Inc. (HTM) Surges: Stock Moves 12.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 25, 8:21AM CDT
U.S. Geothermal Inc. (HTM) was a big mover last session, as the company saw its shares rise by over 12% on the day. (full story)
Why Ormat Technologies (ORA) Has A Bright Short-Term Future? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 7:41AM CDT
Ormat Technologies has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy (full story)
Why Gevo Inc. (GEVO) Is Popping on Thursday
at The Street - Thu Mar 06, 11:20AM CST
Gevo Inc. (GEVO) is popping on Thursday on the announcement alcohol and ethanol producer Porta Hnos S.A. had signed a letter of intent to become the exclusive licensee of Gevo's GIFT(R) technology in Argentina. Gevo is a commercial producer of... (full story)
Porta Hnos S.A. Signs Agreement to Become Exclusive Licensee of Gevo's GIFT(R) Technology in Argentina
GlobeNewswire - Thu Mar 06, 8:24AM CST
Gevo, Inc. (Nasdaq:GEVO), the world's only commercial producer of renewable isobutanol, announced today that Porta Hnos S.A. ("Porta"
has signed a letter of intent to become the exclusive licensee of GIFT(R) in Argentina to produce renewable isobutanol. (full story)
FuelCell Energy (FCEL) Catches Eye: Stock Rises 11.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 8:25AM CST
FuelCell Energy was a big mover last session, with shares rising over 11%. (full story)
Gevo to Host Conference Call to Report Fourth Quarter Financial Results on March 25, 2014
GlobeNewswire - Tue Mar 04, 8:00AM CST
Gevo, Inc. (Nasdaq:GEVO) today announced that the company will host a conference call on Tuesday, March 25, 2014 at 4:30 p.m. EDT (2:30 p.m. MDT) to report its financial results for the fourth quarter ended December 31, 2013 and provide an update on recent corporate highlights. (full story)
Appeals Court Issues Opinion Sending Case Back to District Court
GlobeNewswire - Tue Feb 18, 4:14PM CST
Gevo, Inc. (Nasdaq:GEVO), the world's only commercial producer of renewable isobutanol, announced today that the U.S. Court of Appeals for the Federal Circuit (Appeals Court) issued a decision in a patent case involving Butamax's Patent Nos. 7,851,188 ('188 Patent) and 7,993,889 ('889 Patent). The appeals court offered a new interpretation of a disputed claim term, vacated the district court's prior rulings, and ordered the court to reconsider issues related to infringement and invalidity. (full story)
Overall Average: 40% Sell
Recent stock forum discussions about GEVO http://investorshangout.com/search?q=GEVO&...mp;yt0=Go!
Energy Sector Stocks Technical Data -- Research on Northern Tier Energy, Gevo, MPC, and Tesoro
PR Newswire - Fri May 02, 7:00AM CDT
The trading session on Thursday, May 01, 2014 ended on a mixed note as the Dow Jones Industrial Average finished at 16,558.87, down 0.13% and the NASDAQ Composite closed at 4,127.45, up 0.31%. The S&P 500 finished the day 0.01% lower at 1,883.68. During the trading session, five out of ten sectors finished on a positive note. The S&P 500 Energy Sector Index ended the day 0.36% lower at 683.84, while the index has gained 12.02% in the previous three months. Investor-Edge has initiated coverage on the following equities: Northern Tier Energy L.P. (NYSE: NTI), Gevo Inc. (NASDAQ: GEVO), Marathon Petroleum Corp. (NYSE: MPC) and Tesoro Corp. (NYSE: TSO). Free technical research on NTI, GEVO, MPC and TSO can be downloaded upon signing up at: (full story)
4 Stocks Under $10 Making Big Moves
at The Street - Fri Apr 25, 6:35AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. (full story)
Gevo, Inc. (GEVO) Stock Partially Gives Back Tuesday Gains
at The Street - Wed Apr 23, 2:16PM CDT
Gevo, Inc. (GEVO) stock is tracing lower on Wednesday after making big gains on Tuesday. The renewable biofuel developer soared earlier in the week after announcing Lufthansa will evaluate the company's renewable jet fuel with the aim to approve its... (full story)
Nasdaq stocks posting largest volume increases
AP - Tue Apr 22, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading: (full story)
Why Gevo, Inc. (GEVO) Stock Is Up Today
at The Street - Tue Apr 22, 11:56AM CDT
Gevo, Inc. (GEVO) is soaring on Tuesday after announcing Lufthansa will evaluate the company's renewable jet fuel with the aim to approve its alcohol-to-jet fuel (ATJ) formula for commercial aviation use. Lufthansa will test the fuel with the support... (full story)
Lufthansa to Evaluate Gevo's Renewable Jet Fuel
GlobeNewswire - Tue Apr 22, 11:00AM CDT
Gevo, Inc. (Nasdaq:GEVO), the world's only commercial producer of renewable isobutanol, announced today that it has come to an agreement with Lufthansa to evaluate Gevo's renewable jet fuel with the goal of approving Gevo's alcohol-to-jet fuel (ATJ) for commercial aviation use. Lufthansa's testing is being supported through work with the European Commission. (full story)
Global Synthetic Biology Market 2013-2019 - Genome Engineering, DNA Sequencing, Bioinformatics & Biological Components and Integrated Systems
M2 - Tue Apr 22, 5:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/29nxfg/synthetic_biology) has announced the addition of the "Synthetic Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019" report to their offering. Synthetic biology is a synergistic combination of biology and engineering for the construction of artificial biological system in order to gain desired functions (i.e. to reduce cost or improve efficacy). It comprises nascent technologies that enable synthesis of novel biological parts and organisms that are used in the field of healthcare, chemicals, agriculture and others (biosecurity, R&D and energy and environment). The synthetic biology market is witnessing rapid growth owing to increase in demand for renewable fuels and bio-based chemicals and inexpensive drugs and vaccines that utilizes synthetic biology technologies and products. In addition, participation of various organizations such as BioBricks, DIYbio and SynBERC, for the development of synthetic biology field will further augment the growth of this market during the forecast period. However, high cost and strict regulations to use synthetic biology techniques hampers the growth of this market. Synthetic biology market is segmented mainly by products, by technologies and by applications. Synthetic biology, by product segment is classified as core products and enabling products. Core products are further segmented into synthetic DNA, synthetic genes, synthetic cells, XNA and chassis organisms. The synthetic biology market by core products was dominated by synthetic DNA market in 2012 owing to the commercial availability of this product, compared to other synthetic core products expected to be launched in the market in coming years. Synthetic biology market by technologies is segmented as genome engineering, DNA sequencing, bioinformatics and biological components and integrated systems. Genome engineering technology can be used to modify genetic foods, gene cloning and gene therapy. Thus, application of genome engineering increases the scope to utilize this technique and hence accentuates the growth of this market. Applications of synthetic biology are healthcare, chemicals, agriculture and others. Synthetic biology in healthcare holds largest market share in terms of revenue due to high utilization of synthetic biology techniques to produce cheap drugs and vaccines. Also, commercial availability of synthetic DNA and synthetic genes supports the growth of the healthcare application in the synthetic biology market. Agriculture segment is expected to grow at the highest growth rate during the forecast period. The global synthetic biology market is segmented into the following categories: Products - Core Products - - Synthetic DNA - - Synthetic Genes - - Synthetic Cells - - XNA (Xeno Nucleic Acid) - - Chasis Organisms - Enabling Products - - DNA Synthesis - - Oligonucleotide Synthesis Technologies - Genome Engineering - DNA Sequencing - Bioinformatics - Biological Components and Integrated Systems Applications - Healthcare - Chemicals (Including Bio-Fuels) - Agriculture - Others (Biosecurity, R&D, Energy and Environment) Key Topics Covered: - Introduction - Executive Summary - Market Overview - Global Synthetic Biology Market, by Products - Global Synthetic Biology Market, by Technologies - Global Synthetic Biology Market, by Applications - Global Synthetic Biology Market, by Geography - Competitive Landscape - Recommendations - Company Profiles - Agrivida, Inc. - Amyris, Inc. - Algenol Biofuels, Inc. - ATG:biosynthetics GmbH - Bayer AG - Bristol-Myers Squibb - BIONEER CORPORATION - Biosearch Technologies, Inc. - CBC Comprehensive Biomarker Center GmbH - Cobalt Technologies - DuPont, Inc. - Evolva SA - Exxon Mobil Corporation - Ginkgo Bioworks - GeneWorks Pty Ltd. - Genomatica, Inc. - GeneScript Corporation - Gevo, Inc. - Green Biologics Limited - New England Biolabs, Inc. - OriGene Technologies, Inc. - REG Life Sciences, LLC - Royal DSM - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/29...ic_biology (full story)
Gevo to Host Conference Call to Report First Quarter Financial Results on May 14, 2014
GlobeNewswire - Mon Apr 21, 8:00AM CDT
Gevo, Inc. (Nasdaq:GEVO) today announced that the company will host a conference call on Wednesday, May 14, 2014 at 4:30 p.m. EDT (2:30 p.m. MDT) to report its financial results for the first quarter ended March 31, 2014 and provide an update on recent corporate highlights. (full story)
Gevo, Inc. (GEVO) Enters Oversold Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 9:46AM CDT
Gevo, Inc. (GEVO) Enters Oversold Territory (full story)
Zacks Rank #1 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday (full story)
Why Gevo Inc. (GEVO) Stock Is Plummeting After Hours
at The Street - Tue Mar 25, 3:43PM CDT
Gevo Inc. (GEVO) is tumbling in extending trading after posting a wider-than-expected loss in its year-ending quarter. (full story)
Gevo Reports Fourth Quarter 2013 Financial Results
GlobeNewswire - Tue Mar 25, 3:30PM CDT
Optimizing utilization and cash flows of Luverne plant by producing both isobutanol and ethanol (full story)
U.S. Geothermal Inc. (HTM) Surges: Stock Moves 12.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 25, 8:21AM CDT
U.S. Geothermal Inc. (HTM) was a big mover last session, as the company saw its shares rise by over 12% on the day. (full story)
Why Ormat Technologies (ORA) Has A Bright Short-Term Future? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 7:41AM CDT
Ormat Technologies has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy (full story)
Why Gevo Inc. (GEVO) Is Popping on Thursday
at The Street - Thu Mar 06, 11:20AM CST
Gevo Inc. (GEVO) is popping on Thursday on the announcement alcohol and ethanol producer Porta Hnos S.A. had signed a letter of intent to become the exclusive licensee of Gevo's GIFT(R) technology in Argentina. Gevo is a commercial producer of... (full story)
Porta Hnos S.A. Signs Agreement to Become Exclusive Licensee of Gevo's GIFT(R) Technology in Argentina
GlobeNewswire - Thu Mar 06, 8:24AM CST
Gevo, Inc. (Nasdaq:GEVO), the world's only commercial producer of renewable isobutanol, announced today that Porta Hnos S.A. ("Porta"
has signed a letter of intent to become the exclusive licensee of GIFT(R) in Argentina to produce renewable isobutanol. (full story) FuelCell Energy (FCEL) Catches Eye: Stock Rises 11.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 8:25AM CST
FuelCell Energy was a big mover last session, with shares rising over 11%. (full story)
Gevo to Host Conference Call to Report Fourth Quarter Financial Results on March 25, 2014
GlobeNewswire - Tue Mar 04, 8:00AM CST
Gevo, Inc. (Nasdaq:GEVO) today announced that the company will host a conference call on Tuesday, March 25, 2014 at 4:30 p.m. EDT (2:30 p.m. MDT) to report its financial results for the fourth quarter ended December 31, 2013 and provide an update on recent corporate highlights. (full story)
Appeals Court Issues Opinion Sending Case Back to District Court
GlobeNewswire - Tue Feb 18, 4:14PM CST
Gevo, Inc. (Nasdaq:GEVO), the world's only commercial producer of renewable isobutanol, announced today that the U.S. Court of Appeals for the Federal Circuit (Appeals Court) issued a decision in a patent case involving Butamax's Patent Nos. 7,851,188 ('188 Patent) and 7,993,889 ('889 Patent). The appeals court offered a new interpretation of a disputed claim term, vacated the district court's prior rulings, and ordered the court to reconsider issues related to infringement and invalidity. (full story)
